Trademarkia Logo

Canada

C$
Trademark Search in Canada
ABLEFORM

View On IC.GC.CA

ABLEFORM
ABANDONED SECTION 36

on 21 Sept 2020

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1786211 filed on 8th Jun 2016

ABLEFORM

Trademark usage description

pharmaceutical preparations the form of tablets for use in the treatment of alzheimer's, anemia, anxiety disorders, atherosclerosis, autoimmune diseas Read More

Classification Information

Class [005]
Pharmaceutical preparations the form of tablets for use in the treatment of Alzheimer's, anemia, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely vasomotor symptoms and hot flashes, inflammation and inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, namely metabolic syndrome, migraines, muscle diseases and disorders, namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders, namely Huntington's disease, Alzheimer's disease, Dementia and Parkinson's disease, neurological disorders namely, Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, pancreatic diseases and disorders, psychiatric disorders, namely acute stress disorder, substance abuse, delusions and hallucinations, sleep disorders, urological disorders; antidepressants; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification kind code

10

Class [020]
Packaging containers of plastic for pharmaceutical preparations

Classification kind code

10

Mark Details

Serial Number

1786211

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 12th Jan 2018		Allowed
Submitted for opposition 51
on 12th Jan 2018		Allowance Notice Sent
Submitted for opposition 42
on 27th Sept 2017		Advertised
Submitted for opposition 26
on 7th Sept 2017		Approved
Submitted for opposition 27
on 17th Jul 2017		Approval Notice Sent
Submitted for opposition 20
on 24th Jan 2017		Examiner's First Report
Submitted for opposition 22
on 15th Dec 2016		Search Recorded
Submitted for opposition 31
on 13th Jun 2016		Formalized
Submitted for opposition 1
on 9th Jun 2016		Created
Submitted for opposition 30
on 8th Jun 2016		Filed